A. Termeer

593 total citations
13 papers, 451 citations indexed

About

A. Termeer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, A. Termeer has authored 13 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in A. Termeer's work include Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). A. Termeer is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). A. Termeer collaborates with scholars based in Netherlands. A. Termeer's co-authors include Hans J.M. Smit, Bonne Biesma, Franz M.N.H. Schramel, Egbert F. Smit, C. Debruyne, Johanna N.H. Timmer-Bonte, Nico van Zandwijk, Desmond Curran, Giuseppe Giaccone and Steven Gans and has published in prestigious journals such as Journal of Clinical Oncology, European Respiratory Journal and Lung Cancer.

In The Last Decade

A. Termeer

13 papers receiving 439 citations

Peers

Countries citing papers authored by A. Termeer

Since Specialization

Citations

This map shows the geographic impact of A. Termeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Termeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Termeer more than expected).

Fields of papers citing papers by A. Termeer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Termeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Termeer. The network helps show where A. Termeer may publish in the future.

Co-authorship network of co-authors of A. Termeer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Termeer. A scholar is included among the top collaborators of A. Termeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Termeer. A. Termeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer 2015 ·Lung Cancer ·Wouter W. Mellema, (unknown), Egbert F. Smit, Lizza Hendriks, Joachim G.J.V. Aerts, A. Termeer, (unknown), Hans J.M. Smit, Michel M. van den Heuvel, Anthonie J. van der Wekken, Gerarda J.M. Herder, Frans H. Krouwels, Jos A. Stigt, Ben E.E.M. van den Borne, T. Haitjema, A.J. Staal-van den Brekel, (unknown), E.M. Pouw, Anne‐Marie C. Dingemans	32
2	Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients 2012 ·Radiation Oncology ·(unknown), Esther G.C. Troost, Olga C.J. Schuurbiers, Lioe‐Fee de Geus‐Oei, A. Termeer, Paul N. Span, Johan Bussink	30
3	Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study 2011 ·Journal of Clinical Oncology ·Harry J.M. Groen, Hannie Sietsma, Andrew Vincent, Monique Hochstenbag, John W.G. van Putten, Anke van den Berg, Otilia Dalesio, Bonne Biesma, Hans J.M. Smit, A. Termeer, T. Jeroen N. Hiltermann, Ben E.E.M. van den Borne, Franz M.N.H. Schramel	86
4	A randomized placebo-controlled phase III study of docetaxel/carboplatin with celecoxib in patients (pts) with advanced non-small cell lung cancer (NSCLC): The NVALT-4 study 2009 ·Journal of Clinical Oncology ·Harry J.M. Groen, M. Hochstenbag, (unknown), A. Vincent, (unknown), Bonne Biesma, Hans J.M. Smit, A. Termeer, B.E. van den Borne, (unknown)	3
5	A young female with severe upper abdominal pain and profuse vomiting 2005 ·European Respiratory Journal ·Hildur Harðardóttir, M. E. Keemers-Gels, A. Termeer, Camiel Rosman	2
6	Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study 2005 ·Journal of Clinical Oncology ·Johanna N.H. Timmer-Bonte, Theo M. de Boo, Hans J.M. Smit, Bonne Biesma, (unknown), (unknown), A. Termeer, (unknown), (unknown), Eddy Adang, (unknown), Vivianne C. G. Tjan‐Heijnen	128
7	Regression of invasive thymoma following corticosteroid therapy 2001 ·The Netherlands Journal of Medicine ·A. Termeer	17
8	Video Assisted Thoracoscopic Treatment of Pleuropericardial Cysts 2000 ·Diagnostic and therapeutic endoscopy ·(unknown), (unknown), A. Termeer, W.B. Barendregt, J. Janssen	3
9	Gemcitabine and Cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 Non-Small Cell Lung Cancer: A phase II study of the EORTC Lung Cancer Cooperative Group (EORTC 08955) 2000 ·Lung Cancer ·Nico van Zandwijk, (unknown), G. Kramer, Franz M.N.H. Schramel, Steven Gans, Jan Festen, A. Termeer, N.J.J. Schlösser, C. Debruyne, Desmond Curran, Giuseppe Giaccone	4
10	Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955) 2000 ·Journal of Clinical Oncology ·Nico van Zandwijk, Egbert F. Smit, G. Kramer, Franz M.N.H. Schramel, Steven Gans, Jan Festen, A. Termeer, N.J.J. Schlösser, C. Debruyne, Desmond Curran, Giuseppe Giaccone	114
11	[Achlorhydria and stomach carcinoma]. 1989 ·PubMed ·Ad Masclee, A. Termeer, A.L.M. Verbeek, J H van Tongeren	1
12	Benign clear cell tumour of the lung--intermediate filament typing as a tool in differential diagnosis 1988 ·European Respiratory Journal ·A. Termeer, (unknown), (unknown), (unknown)	4
13	Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients. 1986 ·PubMed ·A. Termeer, A. J. Hoitsma, R. A. P. Koene	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact